FacebookXInstagramTelegram
WhatsApp! 020-122-280-6824

About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
22 05, 2025

Cardano Price Prediction: Supply Shock Looms as Massive ADA Withdrawals Could Fuel Next Rally Toward $1.20

By |2025-05-22T20:58:55+03:00May 22, 2025|Crypto News, News|0 Comments

ADA Eyes $1.20 Breakout as Bullish Channel, On-Chain Growth, and $1B Exchange Outflows Signal Renewed Momentum.

ADA Cardano price is back on the radar after a 5.1% move today, pushing the price up to $0.7645, according to Cardano Feed. It’s not a breakout by any means, but it does mark a shift in tone; sentiment around ADA is starting to turn a bit more optimistic.

Cardano’s ADA climbs 5.1% to $0.7645, signaling renewed optimism as momentum builds ahead of key resistance. Source: Cardano Feed via X

This recent lift adds some weight to the Cardano price prediction. With momentum slowly building both on the charts and within the community, ADA’s approach toward the next resistance zone is beginning to look more encouraging.

Cardano Building Momentum for the Next Move

Cardano’s current structure is forming within an ascending channel, and that’s worth paying attention to. As shown in the latest chart shared by analyst Ali Martinez, ADA has been respecting this upward channel for weeks, bouncing off lower support and forming higher lows, a classic bullish structure in technical terms.

Cardano Price Prediction: Supply Shock Looms as Massive ADA Withdrawals Could Fuel Next Rally Toward .20

Cardano continues to trade within a bullish ascending channel, eyeing $0.92 if $0.72 support holds. Source: Ali Martinez via X

The price is now hovering right near the critical support zone of $0.72, and maintaining this level could be the line between the bullish continuation. If ADA can hold this zone convincingly, the next leg up could target the $0.92 region, which aligns with the top of the ascending channel.

On-Chain Activity Adds Fuel to the Technical Setup

While ADA holds its technical ground near $0.72, Cardano’s on-chain data is starting to reflect that same momentum. According to DappRadar, network activity has picked up pace over the last week, with volume noticeably rising, especially on May 20th, where it nearly touched the $10M mark.

DappRadar

Cardano’s on-chain volume surged to nearly $10M on May 20. Source: DappRadar

This increase in on-chain activity adds credibility to the bullish setup mentioned earlier. When technical structure and network data both begin aligning, it often signals stronger conviction behind a move. If this trend continues, it could be the confirmation bulls are looking for to target higher levels in the coming sessions.

Exchange Outflows Hint at Possible Supply Shock

The latest data shared by TapTools reveals nearly $1 billion worth of ADA has been withdrawn from centralized exchanges since the start of 2025. This kind of outflow is often viewed as a sign of long-term conviction, where holders prefer self-custody over leaving assets exposed on exchanges. Interestingly, the last time Cardano saw outflows of this size was during its 2021 run-up to the $3.10 all-time high.

TapTools

Nearly $1B in ADA exits exchanges in 2025, echoing patterns last seen before Cardano’s $3.10 all-time high. Source: TapTools via X

This shift in supply dynamics complements the technical picture. When a bullish chart setup and increasing on-chain activity are paired with sizable exchange outflows, it suggests that the current price levels may be seen as an accumulation zone and could lead to a supply shock.

Cardano Price Prediction Eyes Beyond Multi-Month Resistance

Cardano’s price action is starting to look textbook as it grinds toward a key multi-month trendline resistance, highlighted in the latest chart by Leader Alpha. It’s not just any resistance; this line has capped ADA since its all-time high, making a breakout here especially significant in terms of long-term trend reversal.

Leader Alpha

Cardano nears breakout from multi-month resistance trendline, with upside targets at $1.20, $1.60, and possibly $3.00. Source: Leader Alpha via X

If ADA successfully flips this resistance, the first key target sits around $1.20, an area of prior liquidity and volume interest. Beyond that, a continuation toward $1.60 and potentially a re-test of the $3.00 ATH zone could come into play if broader market conditions cooperate. This makes the current zone an important technical inflection point for any medium-to-long-term Cardano price prediction.

Final Thoughts: Window of Opportunity

Cardano has not triggered any breakouts yet, but the pieces are starting to line up. Between steady technical structure, rising on-chain activity, and clear signs of long-term holding behavior, ADA is quietly building a case for a larger move.

The big test now sits at the long-standing trendline that’s capped ADA since its all-time high. A clean breakout above that would do more than just push the price higher; it would shift the entire narrative.

Source link

Read More
22 05, 2025

I Thought I Was Too Young to Get Melanoma

By |2025-05-22T20:06:58+03:00May 22, 2025|Fitness News, News|0 Comments


As told to Jacquelyne Froeber

May is Skin Cancer Awareness Month.

How many days a year do you think you were tanning?” my oncologist asked me.

I fidgeted in my seat. Should I tell him the truth?

“Maybe 300,” I said rounding down.

He nearly fell out of his chair.

I didn’t blame him. I knew it was bad. In my defense, I didn’t even know the word melanoma when I was hitting the tanning booths hard in 2012. I was a cheerleader at Indiana State University and our team was sponsored by a tanning salon. Tanning wasn’t just encouraged — it was pretty much mandated. And we didn’t think much about it. After all, who doesn’t want tan legs when you’re standing in front of thousands of people in a mini skirt?

My college cheerleading career was cut short after two years when I tore my Achilles tendon. I cut way back on tanning after my injury and only went for special occasions, like when I got married in 2017. My husband and I had our two kids pretty soon after we were married, and I hardly had a minute alone outside in the sun anymore, let alone time for a tanning booth.

In 2022, I noticed a mole I hadn’t seen before. When it got bigger, I called my doctor to get it checked out. At her office, she did a biopsy and said they would call me in a few days with the results. I thought it was weird that she didn’t check the rest of my body for moles given my history of tanning, but she didn’t seem concerned. So, when the office didn’t call that week, I figured everything was fine.

Ten days later, I was preparing to take my kids to school when I got the call.

I had skin cancer. It was melanoma.

I couldn’t believe what I was hearing. I thought only older people got skin cancer, and I was just 26 with a 1 and 2 year old, and I’d always been healthy. I knew my history of tanning wasn’t good — but I had no clue a deadly form of skin cancer could happen at my age.

I had surgery to remove the mole and cancerous tissue, and I started taking my skin health very seriously. I saw my dermatologist every three months for skin checks.

About a year after the melanoma diagnosis, my daughter came home from daycare with pink eye, and that meant we all got it. In addition to the lovely discharge and weepiness in my eyes, I developed a pain on the side of my left breast. When I told my doctor, she prescribed me more antibiotics, but the pain stuck around.

When I went in for a follow up for the pain, the doctor wanted to prescribe even more antibiotics, but I begged her to order a scan. I knew something was wrong.

She ordered a mammogram, but it didn’t show anything abnormal, even though the pain felt like it was radiating out of my chest.

I finally had an ultrasound, and there was the source of my pain — an enlarged lymph node about 17 times the size of a healthy one. I had a needle biopsy and went home to wait for the results.

A few days later, I called the office but there was no news. Thirteen days after the biopsy I finally got a call: I had cancer.

“But we don’t know what kind of cancer it is yet,” the doctor said.

I didn’t know what I was expecting from the call, but I was stunned. “How do you not know what kind of cancer it is?” I asked.

Kelly, with her husband and two daughters, 2024

Two hours later, the doctor called back and said the cancer was melanoma that had spread to my lymph node. She talked about steps going forward, but I’d already checked out and decided I needed a new doctor. I tried to stay calm and I reminded myself that I was strong and I could get through anything.

That night, a powerful tornado blew through our town and damaged our property. Thankfully, no one was hurt, but the tornado stirred something in me — things felt they were spinning out of control.

I was extremely lucky that my cousin worked in healthcare, and she connected me with an oncologist — one of the best in our area. I had a total lymph node dissection to remove all the lymph nodes in my left arm.

After the surgery, we learned that only one lymph node had cancer. It was the best case scenario, and I sobbed with relief. I still had 26 rounds of immunotherapy to do, but my medical team said I was basically in the clear. It wouldn’t be long before I could get back to my regular life. And I was beyond ready.

The first two rounds of immunotherapy went fine. But when I did blood work for the third round, my thyroid levels were alarmingly high. Like we couldn’t move forward with treatment, high.

I thought it was a mistake. Physically, I didn’t feel like anything was wrong. But my thyroid had completely stopped working, and my blood sugar levels were high, too.

It turned out the immunotherapy drugs had caused my immune system to attack my organs, and now I had what’s called medically induced hypothyroidism and Type 1 diabetes.

Both diseases were side effects of the immunotherapy, which is extremely rare. Still, I couldn’t start treatment again until I had my thyroid and blood sugar levels under control.

I was in survival mode and did whatever the doctors told me to do. But I was struggling. Attempting to manage two new autoimmune diseases was scary and exhausting. And I still had immunotherapy left to do.

In July 2024, I finally finished immunotherapy, but the hits kept coming. My body kept changing after the treatment. I developed heavy bleeding during my period and golf ball-sized cysts on my ovaries. I had to have my tubes tied, which was especially hard because my husband and I wanted to have more kids.

A few months later, I had an enlarged tonsil removed, and the pathologist said the inflammation was from the immunotherapy. This past March, I had to remove my gallbladder — again, inflammation from the immunotherapy drugs.

It’s stunning for me to think that melanoma — and treating melanoma — caused this enormous chaotic ripple in my life. The hardest part is having my kids see me so sick. They’ve asked me what cancer is, and they’re scared to go see healthcare providers (HCPs). But I tell them it’s the opposite: Everyone needs to see a dermatologist to make sure their skin is healthy.

I’ve been working with the Melanoma Research Alliance in the hopes of helping them learn more about what causes rare side effects and how to prevent them. We do know that melanoma isn’t rare, and rates are on the rise for young people. I want everyone to know that going to a dermatologist shouldn’t be seen as a luxury — it’s a necessity — just like going to the dentist. At the end of the day, melanoma doesn’t care how old you are. Getting checked can save your life.

Have your own Real Women, Real Stories you want to share? Let us know.

Our Real Women, Real Stories are the authentic experiences of real-life women. The views, opinions and experiences shared in these stories are not endorsed by HealthyWomen and do not necessarily reflect the official policy or position of HealthyWomen.

From Your Site Articles

Related Articles Around the Web



Source link

Read More
22 05, 2025

Gold (XAUUSD) & Silver Price Forecast: Bulls Eye $3,379 and $34.16 on Safe-Haven Surge

By |2025-05-22T19:10:12+03:00May 22, 2025|Forex News, News|0 Comments


Gold (XAU/USD) is trading at $3,330, pulling back slightly after testing the top of an ascending channel. Price briefly pierced the $3,346 resistance level but failed to close above it, leaving a potential rejection wick that could signal short-term hesitation.

The 50-EMA at $3,274 and the 200-EMA near $3,265 remain supportive beneath, reinforcing the bullish structure as long as higher lows hold. Key levels to watch include immediate resistance at $3,346 and support at $3,302.

A daily close above the top of the channel could target $3,379 next, but if momentum fades, a pullback toward $3,302–$3,265 looks probable. Gold remains bullish but overextended in the short term.



Source link

Read More
22 05, 2025

GBP/USD struggles to clear resistance level after PMI data

By |2025-05-22T19:09:04+03:00May 22, 2025|Forex News, News|0 Comments

GBP/USD Forecast: Pound Sterling struggles to clear resistance level after PMI data

GBP/USD retreats to the 1.3400 area in the European session on Thursday after ending the first three days of the week higher. The pair’s technical outlook highlights a loss of bullish momentum as market focus shifts to Purchasing Managers Index (PMI) data releases from the US.

The data from the UK showed early Thursday that the economic activity in the private sector contracted at a softer pace in May than it did in April, with S&P Global Composite PMI recovering to 49.4 from 48.5. Read more…

GBP/USD bullish price action trade [Video]

In this forex trading video we cover the entry,exit reasons and management for our forex trade today on the GBP/USD and how you can trade the forex structure on daily, four, hourly, and 15 minute charts and how you can target the next support/resistance. In the last few videos we covered the steps to find and trade structure. In this video you will learn how we traded the GBP/USD structure today using the trading charts and price action. Read more…

Source link

Read More
22 05, 2025

XRP Price Prediction: XRP Set for Massive Breakout as $3.87 Target Gains Momentum

By |2025-05-22T18:57:40+03:00May 22, 2025|Crypto News, News|0 Comments

Ripple’s XRP is once again attracting attention as technical indicators, institutional interest, and regulatory speculation converge to set the stage for a potentially explosive move.

After months of trading within a compressed range, XRP appears to be coiling for a sharp breakout, with bullish price targets reaching as high as $3.87.

XRP Price Readies for Breakout as Bullish Indicators Align

Currently trading around $2.35, XRP has shown signs of strength despite short-term corrections. Over the past 24 hours, XRP gained 0.25% with a trading volume surge of nearly 32%, signaling renewed market activity.

XRP is holding strong above the buy zone after a 26% breakout, with bullish momentum aiming for targets up to $3.87. Source: VipRoseTr via X

Crypto analyst VipRoseTr recently identified a breakout from a falling wedge pattern—a classic bullish reversal signal. “The asset jumped from the buy area between $1.85 and $1.90 to hit a local high near $2.40,” the analyst noted. The 26% surge from the reversal zone has placed XRP in a consolidative phase between $2.30 and $2.35, viewed as constructive by technical traders.

Technical Setup Suggests Volatility Ahead

Several indicators on the XRP chart suggest a surge in volatility may be imminent. The daily chart reveals a tightening symmetrical triangle, which often precedes large price moves. Meanwhile, XRP is holding above the 26-day Exponential Moving Average (EMA), supported by the convergence of the 26, 50, and 100 EMAs—forming a classic squeeze pattern.

XRP Price Prediction: XRP Set for Massive Breakout as .87 Target Gains Momentum

The XRP/BTC weekly chart has formed its first golden cross, signaling potential for a significant bullish trend reversal. Source: XRP Update via X

This pattern reflects a build-up in pressure, typically followed by a sharp breakout in either direction. The Relative Strength Index (RSI) is hovering near 60, leaving ample room for upside movement before entering overbought territory.

“XRP has a history of explosive moves when volume contracts near key technical levels,” one analyst said. “The setup is textbook—now we just need a trigger.”

Among the potential upside targets are $2.68, $2.95, and $3.39, with the ambitious $3.87 level acting as the outer boundary of current projections. On the downside, losing support at $2.30 could send XRP back toward $2.26 or even $2.10, where long-term support lies.

ETF Speculation Adds Fuel to the Fire

Much of the current optimism hinges on the outcome of an anticipated decision from the U.S. Securities and Exchange Commission (SEC) regarding a proposed spot XRP ETF. If approved, the fund would mark a historic milestone for Ripple and unlock access for institutional investors, which could send the XRP price soaring.

John Squire

VolatilityShares will launch the first-ever 1x XRP Futures ETF ($XRPI) tomorrow, putting XRP firmly on Wall Street’s radar. Source: John Squire via X

“The market is clearly holding its breath,” said one analyst. “ETF anticipation, combined with XRP’s current chart structure, sets the stage for a dramatic move—one way or another.”

This ETF decision becomes even more significant considering recent SEC activity around Bitcoin and Ethereum ETFs. BlackRock’s Ether ETF received a crucial acknowledgment from the SEC earlier this week, while Dogecoin ETF applications remain under review. The broader market sees these developments as precursors to a more inclusive stance on digital asset ETFs.

Ripple Lawsuit Still Casts a Shadow

While the XRP price is benefiting from bullish momentum, regulatory uncertainty remains a major concern. The Ripple lawsuit against the SEC has not yet reached a final verdict after a long fight. The SEC thinks Ripple’s sale of XRP was an unregistered securities offering, while Ripple thinks XRP must be handled as a commodity or currency.

Despite a partial legal win for Ripple in 2023, the absence of a full settlement is a cloud over the regulatory status of XRP. That, in turn, complicates the introduction of regulated financial instruments like ETFs.

Ripple CEO Brad Garlinghouse stated the company is legally confident. “We think the law is on our side, and we’re prepared to get through this,” Garlinghouse told reporters in a recent interview.

Any regulatory clarity in Ripple’s favor can rekindle investor confidence and contribute to XRP’s potential to retest or even exceed its all-time high of $3.84.

Diverging XRP Price Predictions for 2025

While short-term projections point to $3.87 as a possible target, long-term forecasts for XRP remain mixed. Optimistic analysts predict that Ripple’s native token could surpass $5.00 by year-end 2025, contingent on institutional adoption, favorable legal outcomes, and broader crypto market trends.

XRP

XRP was trading at around $2.41, up 2.77% in the last 24 hours at press time. Source: XRP Liquid Index (XRPLX) via Brave New Coin

However, more conservative models, such as those from Changelly, peg XRP’s 2025 average price around $2.34, with a low-end estimate of $2.10. These figures underscore the uncertainty still surrounding XRP’s journey, especially as the Ripple SEC lawsuit continues to shape market sentiment.

Outlook: Bullish Momentum Builds, But Watch the Triggers

In summary, XRP is displaying strong technical patterns that suggest a breakout could be near. Price action above key EMAs, a breakout from a falling wedge, and the pending ETF decision all point toward a high-stakes moment for Ripple’s digital asset.

If XRP can decisively break the $2.50 resistance zone, analysts anticipate a swift rally toward the $3.00 mark, with the $3.87 level acting as a potential mid-term ceiling. But should the ETF be rejected or the SEC introduce fresh hurdles in the ongoing lawsuit, bearish pressure may reassert itself.

For now, traders and investors alike are watching closely, with XRP news, regulatory updates, and institutional developments at the forefront of what could be one of the year’s most defining crypto market movements.

Stay tuned for more Ripple XRP news and live updates on XRP price trends, the XRP SEC lawsuit, and the evolving Ripple crypto ecosystem.

Source link

Read More
22 05, 2025

Prophecy DeFi Announces Intention to Amend Certain Terms of the $5.36 Million Principal Amount Convertible Debentures Issued in December 2021

By |2025-05-22T17:12:54+03:00May 22, 2025|News, NFT News|0 Comments


Toronto, Ontario–(Newsfile Corp. – May 22, 2025) – Prophecy DeFi Inc. PDFI (“Prophecy DeFi” or the “Company“) announces that it has initiated the process to amend the terms of the previously issued aggregate $5,680,000 principal amount convertible debentures (the “Debentures“) of the Company issued on December 23, 2021, as amended on December 13, 2024. Please refer to the Company’s press release of December 12, 2024 for a complete description of the Debentures and previous amendments. Due to recent conversions, as of today’s date there remains $5,360,000 principal amount outstanding of the Debentures.

The Company will seek written approval from more than 662/3% of the beneficial holders of Debentures by way of written resolution to effect the proposed amendments, as described below (collectively, the “Amendments“). Further, pursuant to Canadian Securities Exchange (“CSE“) policies, the Amendments require approval from the shareholders of the Company. The Company will hold its annual and special meeting to approve, among other things, the Amendments and the Company will provide further details on the date of the meeting in due course.

The Amendments offer the opportunity to restructure the Company’s balance sheet, positioning it to attract new investment capital and pursue business development initiatives.

Key features of the Amendments

Debentures
Terms Original Terms Amendments
Maturity Date  December 23, 2025  No change 
Interest Rate 12% per annum beginning on the effective date of the amendments payable in arrears as a balloon payment on the maturity date. Any accrued and unpaid interest from June 30, 2024, to the effective date will be calculated at 10% per annum and payable as a ballon payment on the maturity date.  No change
Conversion Terms Conversion Price: $0.05 The Company has the right to force conversion of the Debentures at the conversion price if the daily VWAP of the Common Shares on the CSE is greater than $0.10 for 10 consecutive trading days  No change
Forced Conversion In the event the volume weighted average trading price of the common shares in the Canadian Securities Exchange is greater than $0.10 for the preceding 10 consecutive trading days, the Corporation shall have the option to convert the principal amount of the Debentures into common shares of the Corporation at a price of $0.05 per common share. Upon receipt of regulatory approval from the Canadian Securities Exchange and approval of a majority of the shareholders at a meeting of the Corporation’s shareholders, the Corporation shall have the option to force the conversion of the principal amount and accrued and unpaid interest of the Debentures into common shares in the capital of the Corporation at a price of $0.02 per common share without any further action on the part of the holders. 

Requisition in Writing

If the Amendments receive the requisite approval by Debenture holders and the shareholders of the Company at the next annual and special meeting which will be held in due course, the Company and the trustee will enter into a supplemental debenture indenture reflecting the revised terms as noted above.

The Amendments have been conditionally approved by the Canadian Securities Exchange and a further announcement related to the effective date of the Amendments will be provided in due course assuming all consents, shareholder approvals and instruments in writing are obtained.

About Prophecy DeFi

Prophecy DeFi Inc. (PDFI) is a publicly traded investment company whose primary objective is to invest its funds for the purpose of generating returns from capital appreciation and income. It plans to accomplish these goals by bringing together technology start-ups in the Blockchain and Decentralized Finance sectors to fund innovation, elevate industry research, and create new business opportunities in a coherent ecosystem.

www.prophecydefi.com

For further information, please contact:

John McMahon, CEO

Tel: (416) 764-0314

Email: jmcmahon@prophecydefi.com

Forward-Looking Information

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the approval of the Amendments by the Debenture holders and the Debenture holders providing the requisite number of instruments in writing to the trustee, which is required by the Company to proceed with the Amendments. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Accordingly, readers should not place undue reliance on the forward‐looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Neither the CSE nor its Regulation Services Provider (as such term is defined in the policies of the CSE) accept responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE CERVICES OR

FOR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252980



Source link

Read More
22 05, 2025

EUR/USD Forecast Today 22/05: Lira Under Pressure (Chart)

By |2025-05-22T17:07:39+03:00May 22, 2025|Forex News, News|0 Comments

The Turkish Lira (TRY) against the US Dollar (USD) is currently trading at 0.0258, experiencing a sharp decline from its session opening level of 0.0371. This represents a significant negative change of approximately -30.63%, reflecting intense pressure on the Turkish Lira. Throughout the day, the pair has seen a wide price range between a low of 0.0255 and a high of 0.0391, indicating extreme volatility and high market fluctuations.

TRYUSD technical Analysis and Expectations Today:

The pair has been undergoing a sharp decline since the start of the session, with key support levels, notably 0.0300 and 0.0270, being broken. This indicates strong selling momentum. A break below 0.0260 makes 0.0255 a critical support area, and if it’s breached, the price could head towards even lower levels. Technically, Short-term moving averages (such as 20 and 50 days) show a steep downward trend. Also, the Relative Strength Index (RSI) indicates entry into oversold territory, suggesting a potential for a corrective rebound in the near term.

Potential Entry Points:

Bullish Entry Points:

  • 0.0255 if clear reversal signals and an upward rebound emerge.
  • 0.0248 as a potential technical support level if the decline continues.

Bearish Entry Points:

  • 0.0270 if the price rises and resistance appears.
  • 0.0285 as a selling opportunity if the price fails to break through this resistance.

TRYUSD Price Weekly Expectations:

Negative pressure on the Turkish Lira is expected to continue this week, with a possibility of testing the critical support at 0.0250. If this support holds, we might see a corrective rebound towards 0.0270 or 0.0280. However, if it breaks, the price could head to lower levels around 0.0240. Also, movements will be tied to any new developments from the Turkish Central Bank or inflation and interest rate indicators.

USD/TRY Trading Signals:

  • Selling is advised if there’s a weak upward move towards technical resistances without a strong breakout.
  • It’s preferable to monitor for rebound signals before buying from support levels, due to the strong selling momentum.
  • Using stop-loss orders is essential given the sharp volatility.

Tips for USD/TRY Traders:

This period is highly sensitive for trading the Turkish Lira, and long-term trading is not recommended until trends become clearer. Day traders can capitalize on the sharp fluctuations, but with strict risk management.

Ready to trade our Forex daily analysis and predictions? Here are the best Turkish brokers to choose from.

The DFX Team at DailyForex is a group of veteran financial analysts, traders, and brokerage industry experts dedicated to producing in-depth broker reviews and cutting-edge market insights, plus analysis of market trends. Holding over 16 years of experience in global financial markets, and 4 B.A. level academic qualifications in relevant degrees, we conduct thorough, unbiased evaluations of brokers to enable traders make informed decisions, using the most advanced methodology in the industry. Also, the DFX team is involved in generating technical analysis, signals, and trading strategies, with a consistent commitment to accuracy and transparency. Whether you’re a beginner or a professional trader, the DFX Team works to ensure you have the tools and insights you need to succeed as a trader in the retail CFD industry.

Source link

Read More
22 05, 2025

Inositol Market Size, Share | CAGR of 6.5%

By |2025-05-22T16:58:13+03:00May 22, 2025|Dietary Supplements News, News|0 Comments


Report Overview

The Global Inositol Market size is expected to be worth around USD 281.4 Billion by 2034, from USD 149.9 Billion in 2024, growing at a CAGR of 6.5% during the forecast period from 2025 to 2034.

Inositol, a naturally occurring carbohydrate, plays a vital role in various physiological processes, including cell membrane formation, lipid metabolism, and insulin signal transduction. Its significance in human health has led to its widespread application in dietary supplements, pharmaceuticals, and functional foods. The growing awareness of health and wellness among consumers has propelled the demand for inositol concentrates, particularly in regions like India, where the nutraceutical and functional food sectors are expanding rapidly.

Inositol Market Size, Share | CAGR of 6.5%

In India, the food processing industry, which encompasses the production of nutraceuticals and functional ingredients like inositol, is undergoing significant transformation. The Ministry of Food Processing Industries (MoFPI) has implemented several initiatives to bolster this sector. The Production Linked Incentive Scheme for Food Processing Industry (PLISFPI) aims to enhance processing capacity, with an expected processed food output of Rs 33,494 crore and employment generation for nearly 2.5 lakh persons. Such initiatives create a conducive environment for the production and utilization of inositol concentrates within the country.

Furthermore, the establishment of Mega Food Parks across India facilitates the development of a robust infrastructure for food processing. These parks provide state-of-the-art facilities for food processing units, ensuring efficient supply chains and reduced wastage. As of the latest data, 42 Mega Food Parks have been sanctioned, aiming to increase the processing of perishables from 6% to 20% and enhance India’s share in global food trade. Such infrastructure is pivotal for the large-scale production of inositol concentrates, ensuring quality and compliance with international standards.

Key Takeaways

  • Inositol Market size is expected to be worth around USD 281.4 Billion by 2034, from USD 149.9 Billion in 2024, growing at a CAGR of 6.5%.
  • Animal Based Inositol held a dominant market position, capturing more than a 57.5% share in the global inositol market.
  • Food Grade held a dominant market position, capturing more than a 58.2% share in the global inositol market.
  • Powder held a dominant market position, capturing more than a 46.3% share in the inositol market.
  • Dietary Supplements held a dominant market position, capturing more than a 58.9% share in the global inositol market.
  • North America secured a dominant position in the global inositol market, accounting for 37.9% of the total market share, equivalent to approximately USD 56.8 million.

By Source

Animal Based Inositol leads with 57.5% share in 2024 due to its high extraction yield and established use in nutraceuticals.

In 2024, Animal Based Inositol held a dominant market position, capturing more than a 57.5% share in the global inositol market. This leadership is largely due to its high bioavailability and efficient extraction process from animal tissues such as brains and livers, which continue to be a preferred raw material source in pharmaceutical and food supplement industries. Its purity and consistent composition also make it a reliable choice for large-scale production, especially in regions where animal-based derivatives are widely accepted.

Compared to other sources, animal-based inositol offers a better concentration of the compound, enabling manufacturers to maintain quality standards while reducing production costs. As regulatory clarity improves and health awareness grows, demand for such inositol types is expected to stay steady through 2025, particularly in the formulation of mood-enhancing supplements and metabolic health products.

By Grade

Food Grade Inositol commands 58.2% in 2024, driven by rising demand in beverages and health foods.

In 2024, Food Grade held a dominant market position, capturing more than a 58.2% share in the global inositol market. This segment has gained major traction because of the increasing use of inositol in functional foods, energy drinks, infant formula, and dietary supplements. As consumer focus shifts toward clean-label and health-focused products, food-grade inositol is being embraced for its safety, ease of formulation, and compatibility with both liquid and powder-based consumables.

Its presence in fortified products and wellness beverages has expanded notably in Asia and North America, where lifestyle-driven nutritional choices are on the rise. Moving into 2025, the segment is expected to see further growth as more manufacturers reformulate products to include naturally derived ingredients that support mental wellness and metabolic health.

By Form

Powder Form leads with 46.3% share in 2024 thanks to its flexibility in formulation and extended shelf life.

In 2024, Powder held a dominant market position, capturing more than a 46.3% share in the inositol market. Its popularity is rooted in its ease of handling, long shelf stability, and suitability for a wide range of applications—especially in dietary supplements, health drinks, and pharmaceutical preparations. Powdered inositol is widely preferred by manufacturers for its accurate dosing and consistent mixing with other ingredients, making it a go-to form in both consumer health products and clinical nutrition.

It’s also more cost-effective for bulk packaging and shipping, especially in high-volume markets like North America and Europe. As we move into 2025, this format is expected to retain its momentum, particularly with the growing trend toward powdered wellness formulations that can be easily dissolved in water or mixed with smoothies and food.

By Application

Dietary Supplements take the lead with 58.9% share in 2024 as health-conscious consumers drive demand.

In 2024, Dietary Supplements held a dominant market position, capturing more than a 58.9% share in the global inositol market. This strong presence is mainly due to the increasing use of inositol in supplements targeting mental health, hormonal balance, and metabolic functions. Consumers today are more proactive about managing stress, anxiety, and insulin resistance, and inositol-based supplements are gaining popularity for their role in supporting these areas.

The supplement industry has embraced inositol as a naturally derived ingredient with minimal side effects, especially in the form of myo-inositol and D-chiro-inositol. As we head into 2025, this application segment is expected to stay on top, supported by the rise of personalized nutrition and expanding e-commerce platforms that make such supplements more accessible globally.

Inositol Market ShareInositol Market Share

Key Market Segments

By Source

  • Plant Based Inositol
  • Synthetic Inositol
  • Animal Based Inositol

By Grade

  • Food Grade
  • Pharmaceutical Grade
  • Cosmetic Grade

By Form

  • Powder
  • Liquid
  • Capsules
  • Tablets

By Application

  • Dietary Supplements
  • Beverages
  • Feed
  • Pharmaceutical
  • Others

Drivers

Rising Demand for Functional Foods and Dietary Supplements Boosts Inositol Market

One of the primary drivers fueling the growth of the inositol market is the increasing consumer focus on functional foods and dietary supplements that promote overall health and well-being. Inositol, a naturally occurring carbohydrate found in many foods such as fruits, beans, grains, and nuts, plays a crucial role in cellular health, nerve function, and lipid metabolism. Its benefits in managing mental health disorders like anxiety and depression, as well as supporting metabolic health, have raised awareness and boosted demand.

According to the U.S. Department of Agriculture (USDA), food sources rich in inositol, like beans and whole grains, continue to be recommended as part of a balanced diet, encouraging manufacturers to incorporate inositol into a variety of health products. In fact, the USDA’s dietary guidelines emphasize increased consumption of nutrient-dense foods to support mental and metabolic health, indirectly supporting the expansion of inositol use in supplements and fortified foods.

Additionally, government-backed initiatives aimed at improving public health through better nutrition are positively impacting the inositol market. For instance, the National Institutes of Health (NIH) has recognized the importance of micronutrients like inositol in neurological and metabolic functions, prompting increased funding and research into dietary supplements that support such health benefits. This creates a more informed consumer base that seeks out products containing natural ingredients like inositol for preventative health care.

Restraints

High Production Costs and Limited Awareness Restrict Inositol Market Growth

A significant challenge holding back the expansion of the inositol market is the high cost of production combined with limited consumer awareness about the benefits of inositol supplements. Producing high-purity inositol, especially the myo-inositol form widely used in health products, involves complex extraction and purification processes that require advanced technology and strict quality controls. These factors increase manufacturing expenses, which in turn lead to higher prices for end consumers.

According to the Food and Agriculture Organization (FAO), the cost of extracting bioactive compounds like inositol from natural sources such as corn and soy can be substantial due to the need for specialized equipment and energy-intensive methods. This makes it difficult for smaller manufacturers to compete, limiting the variety and affordability of inositol-based products in the market. Additionally, higher retail prices can deter cost-sensitive consumers, particularly in emerging economies where supplement awareness and disposable income remain low.

Moreover, government health campaigns and nutrition programs tend to focus primarily on essential vitamins and minerals, with relatively little emphasis on less well-known compounds like inositol. For example, the World Health Organization’s (WHO) global nutrition strategies prioritize combating micronutrient deficiencies such as iron, vitamin A, and iodine but rarely mention inositol explicitly (WHO, 2023). This lack of official promotion means that consumer education on inositol’s health benefits is limited, which slows market growth by reducing demand.

Opportunity

Expanding Applications in Mental Health and Wellness Present Growth Opportunities for the Inositol Market

One of the most promising growth opportunities for the inositol market lies in its expanding use within mental health and wellness sectors. Inositol has been increasingly recognized for its potential to support neurological functions and improve conditions such as anxiety, depression, and polycystic ovary syndrome (PCOS), making it a valuable ingredient in dietary supplements aimed at these health concerns. This growing awareness is opening new avenues for product innovation and market expansion.

According to the National Institute of Mental Health (NIMH), anxiety disorders affect nearly 20% of adults in the United States each year, highlighting a significant population that could benefit from natural supplements like inositol. Inositol’s role in neurotransmitter signaling, particularly for serotonin and dopamine pathways, offers a non-pharmaceutical option for managing mild to moderate anxiety and mood disorders. This scientific backing is encouraging healthcare providers and consumers to consider inositol supplements as part of holistic wellness approaches.

Government health agencies are also supporting research and education efforts on mental health and nutritional therapies. For example, the U.S. Department of Health and Human Services (HHS) has increased funding for studies exploring the effectiveness of natural compounds in managing mental health, which includes inositol. Such initiatives not only strengthen the scientific evidence base but also help raise public awareness about alternative treatments, boosting demand.

Trends

Inositol’s Role in Women’s Health: A Growing Trend in Dietary Supplements

In recent years, there has been a notable surge in the use of inositol, particularly myo-inositol, in dietary supplements aimed at supporting women’s health. This trend is largely driven by increasing awareness of inositol’s benefits in managing conditions such as polycystic ovary syndrome (PCOS), improving fertility outcomes, and enhancing metabolic health.

The National Institutes of Health (NIH) has highlighted that myo-inositol supplementation can be effective in improving menstrual regularity and ovulation in women with PCOS. Additionally, studies have shown that myo-inositol can reduce the need for gonadotropins in assisted reproductive technology (ART), potentially lowering treatment costs and improving outcomes.

Furthermore, the U.S. Department of Agriculture (USDA) has acknowledged inositol as a source of Vitamin B8, which is isolated from corn steep liquor during the wet milling process. This recognition underscores inositol’s established role in nutrition and its potential applications in various health-related products .

As consumer interest in natural and effective health solutions grows, the demand for inositol-enriched supplements is expected to continue rising. This presents a significant opportunity for manufacturers to develop products that cater to the evolving needs of health-conscious individuals.

Regional Analysis

North America leads the inositol market with 37.9% share in 2024, driven by rising health awareness and robust supplement demand.

In 2024, North America secured a dominant position in the global inositol market, accounting for 37.9% of the total market share, equivalent to approximately USD 56.8 million. This leadership is primarily attributed to the region’s heightened health consciousness and the widespread adoption of dietary supplements. The increasing prevalence of lifestyle-related health issues, such as polycystic ovary syndrome (PCOS), metabolic disorders, and mental health conditions, has spurred demand for inositol-based products, particularly myo-inositol and D-chiro-inositol, known for their therapeutic benefits.

The robust pharmaceutical and nutraceutical sectors in North America have further bolstered the market. Manufacturers are actively investing in research and development to innovate and expand their inositol product portfolios, catering to the evolving consumer preferences for natural and effective health solutions. Additionally, the region’s well-established distribution channels, including online platforms and health stores, have enhanced product accessibility, contributing to market growth.

Inositol Market Regional AnalysisInositol Market Regional Analysis

Key Regions and Countries

  • North America
  • Europe
    • Germany
    • France
    • The UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of MEA

Key Players Analysis

BASF plays a key role in the inositol market through its focus on high-quality nutritional ingredients. The company leverages its strong research and production capabilities to deliver inositol used primarily in dietary supplements and functional foods. BASF emphasizes purity, stability, and regulatory compliance, making it a reliable supplier in both the pharmaceutical and food sectors. Its global presence and partnerships with health-focused brands help it maintain a competitive edge in the growing health and wellness market.

Biocon is actively involved in producing inositol, especially for the pharmaceutical and nutraceutical industries. Known for its biotechnology-driven approach, Biocon offers inositol solutions that support metabolic health and hormonal balance. The company focuses on innovation, affordability, and expanding access to bio-based ingredients. With a growing portfolio of wellness-focused products and a presence in both emerging and mature markets, Biocon strengthens its footprint in health supplements where inositol demand is steadily increasing.

Hebei Yuwei Biotechnology Co. Ltd is a notable Chinese manufacturer of inositol, primarily supplying to food, feed, and pharmaceutical sectors. The company is recognized for cost-effective production and scalable manufacturing capabilities. It exports to multiple international markets and focuses on quality control to meet global standards. Hebei Yuwei’s inositol products are widely used in formulations for mood support, insulin sensitivity, and metabolic balance, making it a key contributor to the supply chain, especially in Asia-Pacific regions.

Top Key Players in the Market

  • BASF
  • Biocon
  • DSM
  • Hebei Yuwei Biotechnology Co. Ltd
  • Holland & Barrett
  • Howtian
  • Lonza
  • Mr. Bill’s Pipe & Tobacco Company
  • Phoenix Herb
  • Ronas Chemicals Ind. Co. Ltd
  • Roquette
  • HOWTIAN

Recent Developments

In 2024, BASF continued to strengthen its position in the inositol market through its Nutrition & Care segment, which generated €1.7 billion in sales during the second quarter alone.

In 2024, Hebei Yuwei Biotechnology Co., Ltd. solidified its position as a key player in the global inositol market. The company achieved an annual production capacity of 6,000 metric tons of inositol, catering to diverse industries such as food, pharmaceuticals, and animal nutrition.

Report Scope



Source link

Read More
22 05, 2025

Ethereum (ETH) Price Prediction for May 21

By |2025-05-22T16:57:01+03:00May 22, 2025|Crypto News, News|0 Comments

The crypto market remains mainly bullish today, according to CoinStats.

ETH chart by CoinStats

ETH/USD

The price of Ethereum (ETH) has gone up by 2.43% over the last day.

Article image
Image by TradingView

On the hourly chart, the rate of ETH is closer to the support than to the resistance. If bulls cannot seize the initiative soon, traders may expect a level breakout, followed by a further correction to the $2,500 zone.

Article image
Image by TradingView

On the bigger time frame, the price of the main altcoin is in the middle of the wide channel, between the support of $2,317 and the resistance of $2,738. 

You Might Also Like

Title news

As neither bulls nor bears are dominating, there are low chances of seeing sharp moves soon.

Article image
Image by TradingView

From the midterm point of view, the rate of ETH has once again bounced off the resistance of $2,608. However, if the weekly bar closes near that mark, traders may witness a blast to the vital zone of $3,000.

Ethereum is trading at $2,571 at press time.

Source link

Read More
22 05, 2025

XRP News: Xrpturbo Goes Live With 25% APY Liquid Staking, Set To Release Governance DApp As $XRT Soars 150%

By |2025-05-22T15:12:00+03:00May 22, 2025|News, NFT News|0 Comments


As XRP bulls gear up for a potential rally and speculation swirls around a Ripple IPO and possible USDC acquisition, a powerful force is emerging from within the XRPL ecosystem.

Xrpturbo, the next-gen DeFi platform has launched its liquid staking at a mouth watering 25% APY.

With the first staking rewards already distributed and major utilities going live, including a Governance & Launchpad DApp on the XRPL Testnet, early adopters are locking in their positions fast.

And those who got in early?

They’re already sitting on 150% gains as XRT lists on BitMart and Xpmarket following a successful presale.

Xrpturbo Liquid Staking Is Live

The wait is over: Xrpturbo’s flagship liquid staking protocol is now live, delivering a 25% APY on XRTstaking.

But this isn’t just another staking pool, it’s non-custodial and built for real DeFi utility.

While many platforms lock your tokens for months, Xrpturbo lets you earn yield without sacrificing liquidity.

The first round of rewards has already hit wallets who held their XRT for the past 30 days, and word is spreading fast.

With staking live and compounding in motion, those sitting on the sidelines risk watching the best yields on XRPL slip through their fingers.

XRT Token Explodes 150%: Still Early?

Following the end of its oversubscribed presale, XRT has surged nearly 150%, fueled by demand from yield chasers and early believers in Xrpturbo’s long-term vision.

Now actively trading on BitMart and Xpmarket, XRT is gaining serious momentum, but this is likely just the beginning.

Why? Because XRT isn’t just another reward token, it’s the key to Defi on XRP:

Staking Incentives

Governance Power

Launchpad Access to upcoming XRPL projects

And soon, real-world integrations built into the ecosystem

With limited supply, growing demand, and expanding utility, XRT is quietly becoming one of XRPL’s most valuable assets.

Governance & Launchpad DApp Launching on XRPL Testnet

As if staking and token growth weren’t enough, Xrpturbo is getting ready to flip the switch on its Governance & Launchpad DApp, which is set to go live on the XRPL Testnet in the coming weeks.

This gives XRT holders direct power over the protocol’s future, from treasury decisions to new project onboarding, while also unlocking access to exclusive token launches on XRPL.

Think of early-stage deals. Community-led funding. Turbocharged innovation.

If you missed the early days of Ethereum DeFi or Solana IDOs, this might be your second chance but on XRPL.

Final Word: The Window Is Closing

XRP is consolidating for what many believe is its next parabolic leg, and Xrpturbo is perfectly positioned at the heart of the XRPL surge.

The protocol is live. Rewards are flowing. Utilities are launching. And the token?

Still undervalued, for now.

Don’t watch from the sidelines. The XRPL DeFi wave is here, and Xrpturbo is leading it.

Join the Xrpturbo movement

To stay ahead of the news, join the XRPTurbo Telegram community today at t.me/xrpturbocom or buy $XRT on BitMart to secure your position before the next price move.

Visit xrpturbo.com to learn more and become part of the next wave of innovation on the XRP Ledger.

Disclaimer: This is a sponsored article. The views and opinions presented in this article do not necessarily reflect the views of CoinCodex. The content of this article should not be considered as investment advice. Always do your own research before deciding to buy, sell or transfer any crypto assets.



Source link

Read More
Go to Top